US OptionsDetailed Quotes

IMMP240816C5000

Watchlist

0.05
0.000.00%

15min DelayClose Jul 23 10:52 ET

0.00High0.00Low

Immutep Stock Discussion

我要向钱看

10 hours ago

FDA Approval!!!

$Immutep(IMMP.US)$ https://www.tipranks.com/news/company-announcements/immutep-advances-cancer-trial-with-fda-approval?futusource=news_stock_stockpagenews&ns_stock_id=75161927894533&src=2&utm_medium=referral&utm_source=moomoo.com&client_hour_clock=24&clientlang=2

Here for P

Jul 22 09:33

Movement

$Immutep(IMMP.US)$ Hmm, still low volume with so many good news, barely any movement 🤔

我要向钱看

Jul 22 08:21

Positive Feedbacks!

$Immutep(IMMP.US)$Immutep gains positive feedback from FDA on phase 3 NSCLC candidate program" data-render="ssr

Trytosaveabit

Jul 22 07:15

$Immutep(IMMP.US)$
Immutep Announces Successful Meeting With FDA On Phase III Design In Non-Small Cell Lung Cancer; TACTI-004 Registrational Trial Will Enrol ~750 Patients Regardless Of PD-L1 Expression In Order To Address The Entire 1l NSCLC Market Eligible For Anti-PD-1 Therapy
Final discussion with the FDA, successfully concluding the regulatory preparations for the TACTI-004 Phase III trial design to evaluate efti in combination with KEYTRUDA (pembrolizumab), MSD's anti-PD-1 therapy, and sta...

$Immutep(IMMP.US)$Immutep Secures US FDA Guidance for Phase Three Lung Cancer Trial

102539778

Jul 17 12:18

$Immutep(IMMP.US)$ waiting and waiting for this to pop

Trytosaveabit

Jul 17 07:13

Hehehe! Even EDGAR Filing beat BENZINGA with news release! Hehehe

$Immutep(IMMP.US)$ Immutep Receives Regulatory Clearance For Phase I Study Of First-In-Class LAG-3 Agonist Antibody Designed To Treat Autoimmune Diseases
Benzinga· 5 mins ago

Trytosaveabit

Jul 17 06:54

New filing!

$Immutep(IMMP.US)$ Immutep Receives Regulatory Clearance for Phase I Study of First-in-Class
LAG-3 Agonist Antibody Designed to Treat Autoimmune Diseases

• Study expected to enrol first participants during Q3 CY2024
SYDNEY, AUSTRALIA – 17 July 2024 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces it has received regulatory clearanc...

Trytosaveabit

Jul 15 08:59

$Immutep(IMMP.US)$ This is being shorted hard on low volume!

No comment yet